Delivering the power of discovery in large pharmaceutical organizations

Abstract

Increasing the output from discovery is currently a major objective for the pharmaceutical industry aimed at reversing recent downward trends in productivity. Although significant attention has been focused on innovative assay and process technologies, these only address specific points in the discovery process. Little effort has been made to manage the multiple interconnected steps within discovery effectively. This manifests itself in low utilization rates of component elements and low expectations of delivery to any agreed timescale.